Advertisement

Latest News

Barriers to Using PCSK9-Targeting Therapies

30 minutes ago

Explore the barriers to PCSK9 inhibitors, their underuse, and how addressing misconceptions can enhance patient outcomes in cholesterol management.

Rethinking Prevention in ASCVD Through Cumulative LDL Exposure

35 minutes ago

Experts discuss evolving strategies in atherosclerosis prevention, emphasizing early intervention and the importance of cholesterol monitoring for better patient outcomes.

Monitoring Considerations with Emerging B-Cell Modulators in IgAN

30 minutes ago

In this segment, the panel discusses how monitoring strategies will need to adapt as B-cell–targeted therapies such as atacicept, sibeprenlimab, and povetacicept move into broader clinical use.

Additional Emerging BAFF and APRIL Inhibitors in IgAN

35 minutes ago

In this segment, the panel reviews the emerging clinical data for two additional BAFF/APRIL–pathway inhibitors: sibeprenlimab and povetacicept.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

35 minutes ago

A study found that higher PM2.5 exposure during the first year after NICU discharge increased asthma risk in children with bronchopulmonary dysplasia by age 5.

Advertisement
Advertisement